 |
Corporate News
10-May-24
|
|
|
|
|
|
|
|
|
|
|
|
Board of Dr Lal Pathlabs allots 2,500 equity shares under ESOP
|
|
|
|
|
|
|
|
The Board of Dr Lal Pathlabs at its meeting held on 10 May 2024 has approved the allotment of 2,500 equity shares under ESOP. Pursuant to the above allotment, the paid-up equity share capital of the Company increased to Rs 83,48,03,520/- divided into 8,34,80,352 equity shares of Rs 10/- each.
|
|
|
|
Previous News |
Dr Lal Pathlabs
(
Results
-
Analysis
12-May-23
10:22
)
|
|
|
Board of Dr. Lal PathLabs recommends final dividend
(
Corporate News
-
12-May-23
10:28
)
|
|
|
Dr Lal Pathlabs consolidated net profit rises 156.62% in the March 2021 quarter
(
Results
-
Announcements
22-May-21
07:56
)
|
|
|
Board of Dr. Lal PathLabs recommends Interim Dividend
(
Corporate News
-
29-Jul-22
10:17
)
|
|
|
Board of Dr. Lal PathLabs recommends second interim dividend
(
Corporate News
-
02-Feb-24
09:28
)
|
|
|
Dr Lal Pathlabs consolidated net profit declines 24.53% in the September 2022 quarter
(
Results
-
Announcements
08-Nov-22
15:26
)
|
|
|
Dr Lal Pathlabs grants 11,500 RSU options
(
Corporate News
-
06-Dec-21
12:15
)
|
|
|
Dr Lal Pathlabs
(
Results
-
Analysis
28-Jul-22
18:13
)
|
|
|
Dr Lal Pathlabs receives reaffirmation in credit ratings for bank facilities
(
Corporate News
-
11-Aug-20
15:07
)
|
|
|
Dr Lal Pathlabs consolidated net profit rises 12.77% in the September 2018 quarter
(
Results
-
Announcements
08-Nov-18
10:31
)
|
|
|
Dr Lal PathLab corrects after four-day rally
(
Hot Pursuit
-
30-Nov-21
09:56
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|